Compare NNNN & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | INOD |
|---|---|---|
| Founded | 2021 | 1988 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2025 | 1993 |
| Metric | NNNN | INOD |
|---|---|---|
| Price | $25.65 | $47.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $91.67 |
| AVG Volume (30 Days) | 73.0K | ★ 1.6M |
| Earning Date | 04-28-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.46 |
| EPS | 0.06 | ★ 1.01 |
| Revenue | $6,920,153.00 | ★ $238,467,000.00 |
| Revenue This Year | N/A | $48.85 |
| Revenue Next Year | N/A | $25.93 |
| P/E Ratio | $410.25 | ★ $43.11 |
| Revenue Growth | N/A | ★ 73.57 |
| 52 Week Low | $5.18 | $26.41 |
| 52 Week High | $55.65 | $93.85 |
| Indicator | NNNN | INOD |
|---|---|---|
| Relative Strength Index (RSI) | 44.80 | 35.20 |
| Support Level | $22.10 | $41.92 |
| Resistance Level | $34.00 | $58.57 |
| Average True Range (ATR) | 6.84 | 5.10 |
| MACD | -0.40 | -1.89 |
| Stochastic Oscillator | 22.21 | 12.80 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.